Literature DB >> 33786719

Context-Specific Tolerance and Pharmacological Changes in the Infralimbic Cortex-Nucleus Accumbens Shell Pathway Evoked by Ketamine.

Gleice Kelli Silva-Cardoso1, Manoel Jorge Nobre2,3.   

Abstract

Like other drugs, ketamine is abused due to its ability to act as a positive reinforcer in the control of behavior, just as natural reinforcers do. Besides, through Pavlovian conditioning, tolerance to drug effects can become conditioned to specific contextual cues showing that environmental stimuli can act as powerful mediators of craving and relapse. In the present study, we shall investigate the effects of long-term ketamine administration and withdrawal on behavioral measures and emotionality, the drug-context-specific influence on the tolerance to the sedative effects of an anesthetic dose of ketamine, and the neuropharmacological events underlying this phenomenon, in rats conditioned with 10 mg/kg of ketamine and later challenged with a dose of ketamine of 80 mg/kg in a familiar and non-familiar environment. Variations in dopamine and serotonin efflux in the infralimbic cortex-nucleus accumbens shell circuitry (IL-NAcSh) was further recorded in the same conditions. Our results highlight that besides its well-known reinforcing properties, ketamine also shares the ability to induce behavioral and pharmacological conditioned tolerance, associated with increases in cortical (IL), and decreases in striatal (NAcSh) dopamine release. To our knowledge, we are presenting the first set of behavioral and neurochemical data showing that, like other drugs of abuse, ketamine can induce learned context-specific tolerance.

Entities:  

Keywords:  Contextual tolerance; Dopamine; Ketamine; Microdialysis; Serotonin

Year:  2021        PMID: 33786719     DOI: 10.1007/s11064-021-03300-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  77 in total

1.  Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice.

Authors:  T Suzuki; T Aoki; H Kato; M Yamazaki; M Misawa
Journal:  Eur J Pharmacol       Date:  1999-12-03       Impact factor: 4.432

Review 2.  Like drugs for chocolate: separate rewards modulated by common mechanisms?

Authors:  Patricia Sue Grigson
Journal:  Physiol Behav       Date:  2002-07

Review 3.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

Review 4.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

Review 5.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

6.  Disruption of tolerance to the ataxic effect of ethanol by an extraneous stimulus.

Authors:  S Siegel; S J Larson
Journal:  Pharmacol Biochem Behav       Date:  1996-09       Impact factor: 3.533

7.  Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice.

Authors:  T Suzuki; H Kato; T Aoki; M Tsuda; M Narita; M Misawa
Journal:  Life Sci       Date:  2000-06-16       Impact factor: 5.037

Review 8.  Neurobiology of opiate abuse.

Authors:  G Di Chiara; R A North
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

9.  Ohmefentanyl stereoisomers induce changes of CREB phosphorylation in hippocampus of mice in conditioned place preference paradigm.

Authors:  Can Gao; Li Wei Che; Jie Chen; Xue Jun Xu; Zhi Qiang Chi
Journal:  Cell Res       Date:  2003-02       Impact factor: 25.617

10.  Glutamate receptor dysfunction and schizophrenia.

Authors:  J W Olney; N B Farber
Journal:  Arch Gen Psychiatry       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.